Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Clinical Trials by Condition
  • Aa
  • Affective Disorders, Psychotic


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com





  • Ocrelizumab for Psychosis by Autoimmunity
    NCT03971487
    Conditions:   Schizo-Affective Type of Psychosis;   Schizophrenia
    Interventions:   Behavioral: Psychosis and cognitive assessments;   Behavioral: Physical and neuro-cognitive evaluations;   Diagnostic Test: Safety labs and electrocardiogram;   Biological: Ocrelizumab infusion
    Sponsors:   The Methodist Hospital System;   Genentech, Inc.
    Recruiting
  • A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
    NCT03261817
    Conditions:   Schizophrenia;   Physical Activity;   Schizo Affective Disorder
    Interventions:   Behavioral: Physical activity (APA);   Behavioral: Health Education program (HE)
    Sponsors:   University Hospital, Caen;   Centre Hospitalier du Rouvray
    Recruiting
  • Correlational Explorations Between Clinical Recovery and Personal Recovery
    NCT04125030
    Conditions:   Psychotic Disorders;   Mood Disorders
    Intervention:   Other: Validation of questionnaires
    Sponsors:   Jean-Francois Pelletier;   Yale University
    Recruiting
  • Levetiracetam in Early Psychosis
    NCT03129360
    Conditions:   Psychosis;   Schizophrenia;   Schizo Affective Disorder;   Schizophreniform
    Intervention:   Drug: Levetiracetam
    Sponsors:   NYU Langone Health;   National Institutes of Health (NIH)
    Recruiting
  • Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
    NCT03943537
    Conditions:   Psychosis;   Schizophrenia;   Schizo Affective Disorder;   Bipolar I Disorder
    Intervention:   Drug: Intranasal Insulin
    Sponsor:   Mclean Hospital
    Not yet recruiting
  • CBT-I as Early Intervention of Mood Disorders
    NCT03000894
    Condition:   Insomnia Due to Mental Disorder
    Intervention:   Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)
    Sponsors:   The University of Hong Kong;   Kowloon Hospital, Hong Kong
    Not yet recruiting
  • L-arginine Study for Persistent Symptoms of Schizophrenia
    NCT04054973
    Conditions:   Schizo Affective Disorder;   Schizophrenia
    Interventions:   Drug: L-arginine;   Drug: Sapropterin Dihydrochloride
    Sponsor:   University of Massachusetts, Worcester
    Recruiting
  • Financial Incentives to Improve Acceptance of Antipsychotic Injections
    NCT03192631
    Conditions:   Schizophrenia;   Schizo Affective Disorder;   Bipolar I Disorder
    Intervention:   Other: Financial incentive
    Sponsor:   Focus Community Mental Health Team
    Not yet recruiting
  • Cromoglycate Adjunctive Therapy for Outpatients With Schizophrenia
    NCT03794076
    Conditions:   Schizophrenia;   Schizo Affective Disorder
    Interventions:   Drug: Cromoglycate;   Drug: Placebo
    Sponsors:   Vishwajit Nimgaonkar, MD PhD;   Stanley Medical Research Institute
    Recruiting
  • D-serine Augmentation of Neuroplasticity
    NCT03711500
    Conditions:   Schizophrenia;   Schizo Affective Disorder
    Interventions:   Drug: D-serine;   Drug: Placebo
    Sponsors:   New York State Psychiatric Institute;   Nathan Kline Institute for Psychiatric Research
    Recruiting
  • Cognitive Effects of Nimodipine in Patients With Schizophrenia
    NCT03671525
    Conditions:   Schizophrenia;   Schizo Affective Disorder
    Interventions:   Drug: Nimodipine;   Drug: Placebo oral capsule
    Sponsor:   Johns Hopkins University
    Recruiting
  • Virtual Reality Avatar Therapy for People Hearing Voices
    NCT04099940
    Conditions:   Psychosis;   Schizophrenia;   Schizo Affective Disorder;   Hearing Voices When No One is Talking (Symptom)
    Interventions:   Behavioral: Virtual Reality Avatar Therapy (VRAT);   Behavioral: Assertiveness Training Program (ATP)
    Sponsor:   Psychiatric University Hospital, Zurich
    Not yet recruiting
  • Reproductive Life Planning for Women With Mental Illness
    NCT03969589
    Conditions:   Psychotic Disorders;   Mood Disorders;   Stress Disorders, Post-Traumatic
    Interventions:   Behavioral: Reproductive Life Planning-Mental Health (RLP-MH) Intervention;   Other: Written Materials on Reproductive Life Planning
    Sponsor:   VA Office of Research and Development
    Recruiting
  • Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training
    NCT04005794
    Conditions:   Schizophrenia;   Schizo Affective Disorder;   Social Skills
    Interventions:   Behavioral: VR social skills training;   Behavioral: Cognitive training
    Sponsor:   Vanderbilt University
    Not yet recruiting
  • Telmisartan Pilot Study on Treatment Resistant Schizophrenia
    NCT03868839
    Conditions:   Schizophrenia;   Schizo Affective Disorder;   Treatment-resistant Schizophrenia
    Intervention:   Drug: Telmisartan Pill
    Sponsor:   Xiaoduo Fan
    Recruiting
  • Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)
    NCT03183609
    Conditions:   Schizophrenia;   Gluten Sensitivity;   Schizo Affective Disorder
    Interventions:   Other: Gluten Flour in Protein Shake;   Other: Rice Flour in Protein Shake
    Sponsor:   University of Maryland, Baltimore
    Recruiting
  • Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
    NCT04004416
    Conditions:   Schizophrenia;   Bipolar Disorder;   Healthy;   Psychosis;   Schizophreniform Disorders;   Schizo Affective Disorder
    Interventions:   Other: Placebo and fMRI;   Drug: Lorazepam and fMRI
    Sponsors:   University of Michigan;   National Institute of Mental Health (NIMH)
    Not yet recruiting
  • Early Psychosis Intervention - Spreading Evidence-based Treatment
    NCT03919760
    Conditions:   First Episode Psychosis;   Schizophrenia, Childhood;   Psychosis;   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorders;   Bipolar I Disorder;   Schizophrenia Spectrum and Other Psychotic Disorders;   Affective Disorders, Psychotic;   Psychotic Disorder Due to Unspecified Substance
    Intervention:   Behavioral: NAVIGATE
    Sponsors:   Centre for Addiction and Mental Health;   Canadian Institutes of Health Research (CIHR);   Institute for Clinical Evaluative Sciences;   North Bay Regional Health Centre;   Health Sciences North;   Niagara Region Public Health;   Lakeridge Health Corporation
    Not yet recruiting
  • Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness
    NCT04118283
    Conditions:   Chronic Pain;   Schizophrenia;   Psychotic Disorders;   Bipolar Disorder;   Affective Disorders, Psychotic
    Interventions:   Behavioral: Cognitive Behavioral Therapy for Chronic Pain;   Behavioral: Health and Wellness
    Sponsors:   VA Office of Research and Development;   VA Maryland Health Care System
    Not yet recruiting
  • Mental Health in Refugees and Asylum Seekers
    NCT03109028
    Condition:   Affective Disorders
    Interventions:   Behavioral: Peer-to-Peer-Groupintervention;   Behavioral: Smartphone-based-Intervention;   Behavioral: Gendersensitive-Groupintervention;   Behavioral: Empowerment-Groupintervention;   Behavioral: Adolescent-Groupintervention;   Other: Treatment as Ususal
    Sponsors:   Charite University, Berlin, Germany;   Zentralinstitut für Seelische Gesundheit Mannheim;   University of Potsdam;   University of Ulm;   Philipps University Marburg Medical Center;   RWTH Aachen University;   Ludwig-Maximilians - University of Munich
    Recruiting
  • A Study of Pregnant and Postpartum Women With and Without Mood Disorders
    NCT03615794
    Conditions:   Bipolar Disorder;   Major Depressive Disorder;   Postpartum Depression;   Postpartum Psychosis
    Intervention:  
    Sponsor:   Johns Hopkins University
    Recruiting
  • Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders
    NCT02819986
    Conditions:   Anxiety;   Mood Disorder
    Intervention:   Behavioral: Progressive Goal Attainment Program
    Sponsor:   St. Joseph's Healthcare Hamilton
    Recruiting
  • Bazedoxifene -Treatment for Women With Schizophrenia
    NCT04113993
    Conditions:   Schizophrenia;   Schizophreniform Disorders;   Schizo Affective Disorder
    Interventions:   Drug: Bazedoxifene Acetate;   Drug: Placebo
    Sponsors:   The Alfred;   Monash University;   Monash Health
    Not yet recruiting
  • Compassion Meditation for Older Adults
    NCT03964246
    Condition:   Anxiety and Mood Disorders
    Interventions:   Behavioral: Compassion Meditation (CM) intervention;   Other: Heathy Aging Psychoeducation
    Sponsor:   VA Office of Research and Development
    Recruiting
  • PrEP and Consumptions
    NCT03449771
    Conditions:   Psychoactive Substance Use;   Mood Disorders
    Intervention:   Other: self-administered questionnaire
    Sponsor:   University Hospital, Montpellier
    Recruiting
  • Targeting Auditory Hallucinations With Alternating Current Stimulation
    NCT03221270
    Conditions:   Schizophrenia;   Schizo Affective Disorder
    Interventions:   Device: tACS (alpha);   Device: Sham tACS (alpha)
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Mental Health (NIMH)
    Recruiting
  • Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART)
    NCT03183388
    Condition:   Mood Disorders
    Intervention:   Behavioral: BE-SMART
    Sponsors:   Yale University;   National Institute of Mental Health (NIMH)
    Recruiting
  • Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder
    NCT03275714
    Condition:   Bipolar Affective Disorder
    Intervention:   Device: Smartphone APP
    Sponsor:   Medical University of Graz
    Recruiting
  • Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
    NCT03860597
    Conditions:   Schizophrenia;   Schizo Affective Disorder;   Schizoaffective Disorder;   Healthy
    Interventions:   Drug: Memantine;   Drug: Placebos
    Sponsor:   University of California, San Diego
    Recruiting
  • Assessment of Cardiac Autonomic Behavior in Patients With Mood Disorders
    NCT01272518
    Conditions:   Mood Disorder;   Mania;   Depression
    Intervention:  
    Sponsor:   Sao Jose do Rio Preto Medical School
    Recruiting
  • Hostile Interpretation Bias Training to Treat Irritability
    NCT03592368
    Conditions:   Irritable Mood;   Mood Disorders
    Intervention:   Device: IBT
    Sponsor:   University of Colorado, Denver
    Recruiting
  • The Analysis of Physical, Physiological and Behavioral Data Collected From Sensors That Track the Mental Condition of Psychiatric Patients
    NCT03714893
    Condition:   Psychiatric Disorders Mood
    Intervention:   Device: Sensor wrist watch
    Sponsor:   Sheba Medical Center
    Not yet recruiting
  • Biological Classification of Mental Disorders
    NCT03984084
    Conditions:   Mental Disorder;   Depressive Disorder;   Anxiety;   Trauma and Stressor Related Disorders
    Intervention:   Other: no intervention
    Sponsor:   Max-Planck-Institute of Psychiatry
    Recruiting
  • Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
    NCT00025935
    Condition:   Mood Disorder
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting
  • Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy
    NCT03691792
    Condition:   Seasonal Affective Disorder
    Interventions:   Behavioral: Cognitive-Behavioral Therapy (CBT-SAD);   Other: Light Therapy
    Sponsors:   University of Vermont;   Teodor Postolache;   Kathryn Roecklein;   Peter Franzen;   Greg Siegle;   David Kolko;   Pamela Vacek
    Recruiting
  • Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders
    NCT03622749
    Conditions:   Bipolar Disorder;   Transcranial Magnetic Stimulation
    Intervention:   Device: Transcranial Magnetic Stimulation (TMS)
    Sponsors:   Massachusetts General Hospital;   National Institute of Neurological Disorders and Stroke (NINDS)
    Not yet recruiting
  • Racing and Crowded Thoughts in Mood Disorders
    NCT02036606
    Condition:   Bipolar Disorder
    Intervention:   Behavioral: questionary
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting
  • Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.
    NCT03249857
    Condition:   Bipolar Affective Disorder
    Interventions:   Behavioral: cognitive tasks + IQ + MINI;   Behavioral: cognitive tasks
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Recruiting
  • Family Study of Affective and Anxiety Spectrum Disorders
    NCT00071786
    Conditions:   Mood Disorders;   Anxiety Disorders
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting
  • Telemetry-Triggered Educational Content Delivery Using MyChart in Mood Disorders
    NCT03575728
    Conditions:   Bipolar Disorder;   Mood Disorders
    Intervention:   Other: MyChart-MHT
    Sponsor:   Sunnybrook Health Sciences Centre
    Recruiting
  • Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
    NCT03088657
    Conditions:   Mood Disorders;   Bipolar Disorder;   Major Depressive Disorder
    Intervention:  
    Sponsors:   Korea University Anam Hospital;   Ministry of Health & Welfare, Korea;   Seoul National University Hospital;   Severance Hospital;   Seoul National University Bundang Hospital;   Samsung Medical Center;   Gyeongsang National University Hospital;   Pusan National University Hospital;   Chonnam National University Hospital;   National Center for Mental Health, Korea
    Recruiting
  • Financial Incentives to Improve Medication Adherence
    NCT04191876
    Conditions:   Schizophrenia;   Schizo Affective Disorder;   Bipolar Disorder;   Depression
    Intervention:   Other: Wellth - Financial Incentives
    Sponsor:   Northwell Health
    Recruiting
  • Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
    NCT04091139
    Conditions:   Depressive Disorder;   Anxiety Disorders
    Interventions:   Behavioral: Unified protocol for adolescents (UP-A);   Behavioral: Treatment as usual (TAU)
    Sponsors:   Chinese University of Hong Kong;   Castle Peak Hospital
    Recruiting
  • A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth
    NCT03911414
    Conditions:   Mood Disturbance;   Mood Disorders;   Natural Supplements;   Alternative Treatment
    Interventions:   Drug: Open-label Treatment with Omega-3 Fatty Acids + Inositol;   Drug: Open-label Treatment with N-acetylcysteine
    Sponsor:   Massachusetts General Hospital
    Recruiting
  • Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal
    NCT02721316
    Conditions:   Mood Disorder;   Reactive Depression
    Intervention:   Other: Supported with intensive nursing follow post hospitalization
    Sponsor:   University Hospital, Montpellier
    Not yet recruiting
  • Validation of the Ontological Addiction Scale
    NCT04137471
    Conditions:   Mood Disorders;   Emotional Disorder
    Intervention:  
    Sponsor:   University Hospital, Montpellier
    Recruiting
  • A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women
    NCT03774641
    Conditions:   Bipolar Disorder;   Major Depressive Disorder;   Schizo Affective Disorder
    Intervention:   Drug: Lamictal
    Sponsor:   Johns Hopkins University
    Recruiting
  • Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study
    NCT03523767
    Condition:   Major Depressive Disorder
    Interventions:   Biological: S.typhi Injection;   Biological: Normal Saline Injection
    Sponsor:   The University of Texas Health Science Center, Houston
    Recruiting
  • Anti-stigma Intervention for Chinese American Older Adults
    NCT03820297
    Conditions:   Mood Disorders;   Anxiety Disorders
    Intervention:   Behavioral: 10 sessions of ASGI
    Sponsors:   NYU Langone Health;   Substance Abuse and Mental Health Services Administration (SAMHSA)
    Not yet recruiting
  • Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
    NCT03608449
    Conditions:   Anxiety Disorder;   Affective Disorders;   Personality Disorders
    Intervention:   Other: questionnaires
    Sponsor:   Shalvata Mental Health Center
    Not yet recruiting
  • Digital Training for Non-Specialist Health Workers to Deliver a Brief Psychological Treatment for Depression
    NCT04157816
    Conditions:   Depression;   Mental Disorder;   Psychological
    Interventions:   Other: Face-to-Face Training;   Other: Digital Training;   Other: Coaching Support
    Sponsors:   Harvard Medical School;   Sangath
    Not yet recruiting
  • Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
    NCT02824627
    Conditions:   Mood Disorder;   Disruptive Behavior Disorders
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsor:   University of Nebraska
    Recruiting
  • Multimodal Imaging of ECT Effects
    NCT02871141
    Condition:   Major Depressive Disorder
    Interventions:   Procedure: electroconvulsive therapy;   Drug: Antidepressant
    Sponsor:   Charite University, Berlin, Germany
    Recruiting
  • Promoting Widowed Elders Lifestyle After Loss
    NCT02631291
    Conditions:   Mood Disorders;   Depression;   Anxiety;   Grief;   Bereavement;   Health Behavior
    Interventions:   Behavioral: Behavioral self-monitoring;   Behavioral: Behavioral self-monitoring + Motivational interviewing
    Sponsor:   University of Pittsburgh
    Recruiting
  • Thoughts and Health - Preventing Depression in Adolescents
    NCT04128644
    Conditions:   Depression;   Adolescent Development;   Mental Disorder, Child
    Interventions:   Behavioral: Thoughts & health;   Other: Treatment as Usual
    Sponsor:   Vastra Gotaland Region
    Not yet recruiting
  • Technology Enhanced Family Treatment
    NCT03913013
    Conditions:   Mood Disorders;   Bipolar Disorder;   Major Depression
    Intervention:   Behavioral: Family-Focused Treatment with MCC App
    Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH)
    Recruiting
  • Prevalence of Mood Disorders and Mental Health Service Use Among Immigrants in Santiago, Chile
    NCT04114565
    Condition:   Major Depressive Disorder
    Intervention:  
    Sponsors:   Pontificia Universidad Catolica de Chile;   Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
    Recruiting
  • Quantitative Investigation of Environment and Participation
    NCT04106960
    Conditions:   Supported Accommodation Residents;   Schizophrenia, Shizotypal and Delusional Disorders;   Mood Affective Disorders;   Disorders of Adult Personality and Behavior
    Intervention:   Other: No Intevention Used
    Sponsors:   Queen Margaret University;   NHS Lothian
    Not yet recruiting
  • The Psychobiology of Childhood Temperament
    NCT00060775
    Conditions:   Mood Disorders;   Anxiety Disorders;   Adolescents
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting
  • A Study on Better Cognitive Functioning Through Braintraining on the Internet
    NCT04006756
    Conditions:   Depression;   Late Life Mood Disorder;   Impaired Cognition;   Alteration in Mood;   Alteration in Cognition
    Interventions:   Behavioral: Online cognitive training 1;   Behavioral: Online cognitive training 2
    Sponsor:   VU University Medical Center
    Not yet recruiting
  • Imaging SV2A in Mood Disorders
    NCT02734602
    Conditions:   Major Depressive Disorder;   Post-Traumatic Stress Disorder
    Interventions:   Drug: Ketamine;   Behavioral: Cognitive Testing;   Radiation: PET;   Device: MRI
    Sponsors:   Yale University;   VA Office of Research and Development
    Recruiting
  • Effectiveness of the First French Psychoeducational Program on Unipolar Depression
    NCT02501226
    Conditions:   Unipolar Depressed Outpatients;   Mild Severity;   Without Psychotic Features
    Interventions:   Other: Treatment as usual;   Behavioral: ENVIE psychoeducational program
    Sponsors:   University Hospital, Montpellier;   Groupe Hospitalier de la Rochelle Ré Aunis;   Centre Hospitalier Universitaire de Besancon;   Centre Hospitalier Béziers;   University Hospital, Clermont-Ferrand;   Centre Hospitalier Universitaire de Nice;   Centre Hospitalier de l'Agglomération de Nevers;   Centre Psychothérapique de Nancy;   Hôpitaux à Bron;   Assistance Publique - Hôpitaux de Paris;   Centre Hospitalier Esquirol
    Recruiting
  • Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials
    NCT03033420
    Conditions:   Affective Disorders;   Unipolar Depression;   Bipolar Disorder
    Intervention:   Device: A smartphone-based monitoring system including a) an integrated feedback loop between patients and clinicians and b) context-aware CBT modules
    Sponsors:   Psychiatric Centre Rigshospitalet;   Technical University of Denmark
    Recruiting
  • Effect of Behavioral Intervention on Cannabinoid Receptors in BAD
    NCT04168697
    Conditions:   Bipolar Affective Disorder, Currently in Remission;   Bipolar Disorder I;   Bipolar Disorder II
    Intervention:   Behavioral: Wim Hof method
    Sponsor:   Wayne State University
    Not yet recruiting
  • DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole
    NCT03881449
    Conditions:   Schizophrenia;   Major Depressive Disorder;   Bi-Polar Disorder;   Schizo Affective Disorder
    Intervention:   Combination Product: ABILIFY MYCITE
    Sponsors:   Durham VA Medical Center;   Otsuka Pharmaceutical Development and Commercialization, Inc.
    Recruiting
  • EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
    NCT04123483
    Conditions:   Premenstrual Syndrome;   Premenstrual Dysphoric Disorder;   Premenstrual Tension;   Menstrual Related Mood Disorder
    Intervention:   Drug: EnBrace HR Softgel
    Sponsors:   Massachusetts General Hospital;   JayMac Pharmaceuticals, LLC
    Not yet recruiting
  • Targeting Adolescent Depressive Symptoms Via Brief, Web-Based Interventions
    NCT04066985
    Conditions:   Depression;   Depressive Disorder;   Behavioral Symptoms;   Mood Disorders;   Mental Disorders
    Interventions:   Behavioral: Growth Mindset Online Single-Session Program;   Behavioral: Self-Kindness Online Single-Session Program;   Behavioral: Supportive Therapy Online Single-Session Program (Control)
    Sponsors:   Child Mind Institute;   Stony Brook University
    Recruiting
  • Effects of Behavioural Activation on Emotional Cognition and Mood
    NCT03995186
    Conditions:   Depression;   Depressive Disorder;   Mood Disorders;   Cognition
    Interventions:   Behavioral: Behavioural activation;   Behavioral: Activity monitoring
    Sponsor:   University of Oxford
    Recruiting
  • Electronic Communication Augmented Mental Health Care
    NCT03925038
    Conditions:   Depressive Disorder;   Anxiety Disorders;   Bipolar Affective Disorder
    Interventions:   Behavioral: Augmented Care: Electronic media dashboard;   Behavioral: Treatment as Usual
    Sponsors:   Johns Hopkins University;   Once Upon a Time Foundation
    Recruiting
  • Mechanisms of Rumination Change in Adolescent Depression
    NCT03859297
    Conditions:   Major Depressive Disorder;   Mood Disorders
    Interventions:   Behavioral: Rumination-Focused CBT;   Behavioral: Relaxation-based Therapy
    Sponsors:   University of Utah;   University of Exeter;   National Institute of Mental Health (NIMH)
    Recruiting
  • Effects of Seven Day Prucalopride Administration in Healthy Volunteers
    NCT03572790
    Conditions:   Molecular Mechanisms of Pharmacological Action;   Depression;   Depressive Disorder;   Mood Disorders;   Mental Disorders;   Antidepressive Agents;   Cognition
    Interventions:   Drug: Prucalopride;   Other: Placebo
    Sponsor:   University of Oxford
    Recruiting
  • Ketamine for Mood Disorders With Suicidal Ideation
    NCT04099771
    Conditions:   Depressive Disorder, Major;   Suicidal Ideation
    Intervention:   Drug: Ketamine
    Sponsor:   The Miriam Hospital
    Recruiting
  • Citalopram and Stress Reactivity
    NCT04161209
    Conditions:   Depression;   Depressive Disorder;   Mental Disorder;   Antidepressive Agents;   Cognition;   Stress
    Interventions:   Drug: Citalopram;   Other: Placebo
    Sponsors:   University of Oxford;   University of Bath
    Recruiting
  • Citalopram and Self Emotional Processing
    NCT04169230
    Conditions:   Molecular Mechanisms of Pharmacological Action;   Depression;   Depressive Disorder;   Mental Disorder;   Antidepressive Agents;   Cognition
    Interventions:   Drug: Citalopram;   Drug: Placebo oral tablet
    Sponsors:   University of Oxford;   University of Bath
    Recruiting
  • Reaching and Engaging Depressed Senior Center Clients (REDS)
    NCT03246789
    Conditions:   Depression, Unipolar;   Mental Health Disorder
    Interventions:   Behavioral: Engage-M;   Behavioral: Wellness in Mind and Body
    Sponsors:   Weill Medical College of Cornell University;   New York City Department for the Aging;   National Institute of Mental Health (NIMH)
    Recruiting
  • Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS)
    NCT03680664
    Conditions:   Anxiety Disorders;   Mood Disorders;   Transcranial Direct Current Stimulation;   tDCS;   Stress Reduction
    Interventions:   Device: Active tDCS;   Other: sham tDCS;   Behavioral: MBSR
    Sponsors:   Centre for Addiction and Mental Health;   University of Toronto
    Recruiting
  • An Investigation of the Relationship Between Omega-3 Fatty Acid Nutrition and Mental Health in Children and Adolescents
    NCT04158869
    Conditions:   Major Depressive Disorder;   Depression;   Child Mental Disorder
    Intervention:  
    Sponsors:   Swiss Federal Institute of Technology;   Psychiatric University Hospital, Zurich
    Recruiting
  • Cooperation for Primary Care Patients on Sick Leave for CMD: Care Manager and Workplace Intervention - CO-WORK-CARE
    NCT03250026
    Conditions:   Depressive Disorder;   Anxiety Disorders
    Interventions:   Behavioral: Workplace convergence dialogue;   Behavioral: Care Manager
    Sponsors:   Göteborg University;   Vastra Gotaland Region
    Recruiting
  • Assisted Animal Therapy: ReAnimal
    NCT03898843
    Conditions:   Anxiety;   Mood Disorders;   Post Traumatic Stress Disorder
    Interventions:   Other: Animal assisted therapy;   Biological: Nasal swab sampling;   Behavioral: STAI-Y and POMS Questionnaires;   Procedure: physiological parameters measure;   Other: Visual Analog Scale (VAS);   Behavioral: Impact of Event Scale - Revised (IES-R);   Behavioral: satisfaction questionnaire;   Biological: Rectal swab sampling
    Sponsor:   Hospices Civils de Lyon
    Not yet recruiting
  • An Eye Tracking Study of Affective Disorder Patients With Suicide Risk
    NCT03711045
    Conditions:   Major Depressive Disorder;   Bipolar Disorder;   Suicide
    Intervention:   Behavioral: eye-tracking
    Sponsor:   Central South University
    Recruiting
  • Seasonal Affective Disorder and Visual Impairment
    NCT03403959
    Conditions:   Seasonal Affective Disorder;   Visual Impairment
    Intervention:   Device: light therapy
    Sponsors:   Psychiatric Centre Rigshospitalet;   Glostrup University Hospital, Copenhagen
    Recruiting
  • Cannabidiol as an Adjunctive Treatment for Bipolar Depression
    NCT03310593
    Conditions:   Bipolar Disorder;   Bipolar Depression;   Bipolar Affective Disorder
    Interventions:   Drug: Cannabidiol;   Drug: Placebo
    Sponsors:   Hospital de Clinicas de Porto Alegre;   Federal University of Rio Grande do Sul;   University of Sao Paulo
    Recruiting
  • Validation of an Automated Online Language Interpreting Tool - Phase Two.
    NCT03538860
    Conditions:   Mood Disorder;   Anxiety Disorder;   Substance Use Disorder;   Chronic Medical Condition
    Interventions:   Behavioral: Active comparator: Human interpreter;   Behavioral: Intervention: Asynchronous Telepsychiatry
    Sponsors:   University of California, Davis;   Agency for Healthcare Research and Quality (AHRQ)
    Recruiting
  • Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy
    NCT03591224
    Conditions:   Depression;   Anxiety;   Major Depressive Disorder;   Generalized Anxiety Disorder;   Mood Disorders
    Interventions:   Other: Pharmacogenomic Testing;   Other: Pharmacist Standard of Care
    Sponsors:   John Papastergiou Pharmacy Ltd;   Green Shield Canada
    Recruiting
  • Technology Enhanced Behavioral Activation Treatment for Substance Use
    NCT02707887
    Conditions:   Substance-Related Disorders;   Depressive Disorder;   Behavioral Symptoms;   Risk-Taking;   Sexual Behavior
    Interventions:   Behavioral: LETS ACT;   Behavioral: LETS ACT-SE;   Behavioral: Treatment as Usual
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • The Police-Mental Health Linkage System
    NCT03740139
    Conditions:   Mental Disorders, Severe;   Schizophrenia and Related Disorders;   Bipolar Disorder;   Depressive Disorder
    Intervention:   Other: The Police-Mental Health Linkage System
    Sponsors:   New York State Psychiatric Institute;   National Institute of Mental Health (NIMH)
    Recruiting
  • Correlation Study Between Mental Behavioral Symptoms in Dementia Patients and Mood Disorders of Caregivers
    NCT03724344
    Condition:   Dementia
    Intervention:   Other: Cross section resaerch
    Sponsor:   Shanghai Mental Health Center
    Recruiting
  • Proactive, Personalized Postpartum Mental Healthcare
    NCT03803189
    Conditions:   Postpartum Depression;   Postpartum Blues;   Postpartum Anxiety;   Postpartum Mood Disorder
    Intervention:   Behavioral: Usual care plus eToolkit
    Sponsors:   Women's College Hospital;   Canadian Institutes of Health Research (CIHR);   North York General Hospital;   Michael Garron Hospital
    Recruiting
  • Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
    NCT02845453
    Conditions:   Substance Use Disorders;   Bipolar Disorder;   Mood Disorders
    Interventions:   Drug: Quetiapine;   Drug: Placebo
    Sponsor:   Massachusetts General Hospital
    Recruiting
  • Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
    NCT00024635
    Conditions:   Mood Disorder;   Anxiety Disorder;   Healthly Volunteers;   Bipolar Disorders;   Depression
    Intervention:  
    Sponsors:   National Institute of Mental Health (NIMH);   Suburban Hospital
    Recruiting
  • Keeping Well:Online Cognitive Behavioral Therapy (CBT) for Pregnant Women With Depressive Symptoms
    NCT01909167
    Conditions:   Anxiety;   Mental Disorders;   Postpartum Depression;   Depressive Symptoms
    Interventions:   Behavioral: Online Cognitive Behavioral Therapy (CBT);   Other: Treatment as usual
    Sponsor:   Imperial College London
    Not yet recruiting
  • A Personalized Approach to Effects of Affective Bias Modification on Symptom Change and Rumination
    NCT04137367
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Affective bias modification;   Behavioral: Sham Affective bias modification
    Sponsors:   University of Oslo;   Extrastiftelsen;   Diakonhjemmet Hospital;   University of Oxford
    Recruiting
  • Resilience in Adolescent Development
    NCT03458936
    Conditions:   Risk Assessment;   Resilience, Psychological;   Depression;   Mood Disorders;   Anxiety Disorders
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting
  • Study of Premenstrual Syndrome and Premenstrual Dysphoria
    NCT00001177
    Conditions:   PMS;   Premenstrual Mood Disorder;   PMDD;   Depression
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting
  • Continuous Theta Burst Stimulation as an add-on Treatment for Bipolar Depression
    NCT03603561
    Conditions:   Bipolar Disorder;   Bipolar Depression;   Bipolar I Disorder;   Bipolar II Disorder;   Depression;   Mood Disorders;   Mental Disorder
    Interventions:   Device: cTBS;   Device: Sham cTBS
    Sponsors:   Universiteit Antwerpen;   Universitair Ziekenhuis Brussel
    Recruiting
  • e-Mindfulness for Depression
    NCT03922217
    Conditions:   Depression;   Mental Health Disorder
    Intervention:   Device: Mindful My Way
    Sponsor:   Washington University School of Medicine
    Recruiting
  • A Family Depression Prevention Program
    NCT02021578
    Condition:   Depression
    Interventions:   Behavioral: Family Cognitive Behavioral Prevention;   Behavioral: Written information
    Sponsors:   Vanderbilt University;   San Diego State University
    Recruiting
  • Mobile Virtual Positive Experiences for Anhedonia
    NCT03715400
    Conditions:   Anhedonia;   Virtual Reality;   Depression;   Mood Disorders
    Intervention:   Behavioral: Positive Virtual Reality Training
    Sponsor:   University of California, Los Angeles
    Recruiting
  • Mood Disorders Bladder Cancer
    NCT04036877
    Condition:   Bladder Cancer
    Intervention:   Other: Mood Disorder Assessment
    Sponsor:   University of Kansas Medical Center
    Recruiting
  • Heart Rate Variability as a Clinical Marker in a Population of Anxio-depressive Patients
    NCT04192669
    Condition:   Anxio Depressive Disorder
    Intervention:   Device: Heart rate monitoring
    Sponsor:   Tatiana Besse-Hammer
    Recruiting
  • A Clinical Trial of Fluvoxamine for Melancholia
    NCT04160377
    Conditions:   Depressive Disorder;   Endogenous Depression;   Melancholia
    Intervention:   Drug: Fluvoxamine
    Sponsor:   Lingjiang Li
    Recruiting
  • A Study to Evaluate the Benefit of Opti-Me Application to Different Treatments of MDD
    NCT04148612
    Condition:   Depressive Disorder, Major
    Intervention:   Diagnostic Test: Opti-Me
    Sponsor:   ElMindA Ltd
    Not yet recruiting
  • Appalachian Mind Health Initiative
    NCT04120285
    Condition:   Major Depressive Disorder
    Intervention:   Behavioral: remote internet-based cognitive behavior therapy (eCBT)
    Sponsors:   West Virginia University;   Patient-Centered Outcomes Research Institute
    Not yet recruiting
  • Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
    NCT04101474
    Condition:   Treatment Resistant Depression
    Intervention:   Drug: Ketamine
    Sponsor:   Assiut University
    Not yet recruiting
  • Ketamine for Treatment Resistant MDD
    NCT04021433
    Condition:   Depressive Disorder, Major
    Intervention:   Drug: Ketamine
    Sponsor:   Hadassah Medical Organization
    Recruiting
  • Cerebellar Stroke and Mood Disorders
    NCT03515486
    Condition:   Stroke
    Intervention:   Other: Post stroke mood disorders evaluation
    Sponsor:   University Hospital, Bordeaux
    Recruiting
  • Mini Theta Burst TMS in MDD Patients
    NCT04014959
    Condition:   Major Depressive Disorder
    Intervention:   Combination Product: TMS/ fMRI Stimulation
    Sponsor:   University of Pennsylvania
    Recruiting
  • The Role of HNKs in the Antidepressant Effect of Ketamine
    NCT03977675
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Ketamine
    Sponsor:   Columbia University
    Recruiting
  • Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of Probiotics
    NCT03893162
    Condition:   Major Depressive Disorder
    Interventions:   Dietary Supplement: Multi-strain probiotic;   Other: Placebo
    Sponsor:   King's College London
    Recruiting
  • Scopolamine in Healthy Volunteers
    NCT03874130
    Condition:   Major Depressive Disorder (MDD)
    Intervention:   Drug: Scopolamine
    Sponsor:   Repurposed Therapeutics, Inc.
    Recruiting
  • Improving Brain Stimulation Through Imaging
    NCT03851380
    Conditions:   Depression;   Depressive Disorder, Treatment-Resistant
    Interventions:   Behavioral: Psychological / Functional Assessment;   Other: Structural and Functional MRI;   Device: Transcranial Magnetic Brain Stimulation and MR Image Guidance
    Sponsors:   VA Office of Research and Development;   Providence VA Medical Center;   Atlanta VA Medical Center
    Recruiting
  • ROOM-LIGHT: Effect of a Dynamic Lighting System in Depressed Inpatients
    NCT03821506
    Condition:   Major Depressive Disorder
    Interventions:   Device: Dynamic Light;   Device: Usual care
    Sponsors:   Mental Health Centre Copenhagen;   Mental Health Services in the Capital Region, Denmark;   Toyota-Fonden;   Grosserer L. F. Foghts Fond Denmark;   ELFORSK Danish Energy;   Technical University of Denmark
    Recruiting
  • Contact: Developing New Clinical Management Strategies
    NCT03812588
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Escitalopram;   Drug: Placebo
    Sponsors:   New York State Psychiatric Institute;   University of Haifa
    Recruiting
  • The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health
    NCT03795688
    Conditions:   Major Depressive Disorder;   Perinatal Depression
    Intervention:   Other: Pregnancy
    Sponsors:   Vibe G Frøkjær, MD, PhD;   Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak;   Mental Health Centre Copenhagen;   University of Copenhagen
    Recruiting
  • Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
    NCT03779789
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Vortioxetine;   Drug: Sertraline;   Drug: citalopram;   Drug: Escitalopram;   Drug: Paroxetine;   Drug: Fluoxetine;   Drug: Fluvoxamine
    Sponsors:   Azienda Ospedaliera Universitaria Integrata Verona;   University of Catania
    Not yet recruiting
  • Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive Disorder
    NCT03754712
    Condition:   MDD
    Intervention:   Dietary Supplement: Vitamin D3
    Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
    Recruiting
  • Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS)
    NCT03718013
    Condition:   Major Depressive Disorder
    Interventions:   Device: accelerated deep TMS;   Device: standard deep TMS
    Sponsor:   Sveti Ivan Psychiatric Hospital
    Recruiting
  • Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
    NCT03715127
    Condition:   Depressive Disorder, Major
    Interventions:   Drug: Psilocybine oral capsule;   Drug: Placebo oral capsule
    Sponsors:   University of Zurich;   Schweizerischer Nationalfonds
    Recruiting
  • Maintenance of Response After rTMS for Depression Using tDCS
    NCT03708159
    Condition:   Major Depressive Disorder
    Interventions:   Device: active tDCS + mindfulness meditation;   Other: sham tDCS + mindfulness meditation
    Sponsors:   Centre for Addiction and Mental Health;   University Health Network, Toronto
    Recruiting
  • Ketamine Co-induction for Patients With Major Depressive Disorder
    NCT03666494
    Conditions:   Ketamine;   Depression;   Anesthesia
    Interventions:   Drug: Ketamine Hydrochloride;   Drug: Propofol;   Drug: Fentanyl
    Sponsor:   University of Saskatchewan
    Not yet recruiting
  • Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study
    NCT03606850
    Condition:   Major Depressive Disorder
    Intervention:   Device: Measurements of markers of cortical excitability by TMS
    Sponsors:   Centre Hospitalier du Rouvray;   Centre hospitalier de Ville-Evrard, France;   University Hospital Caen, France
    Recruiting
  • Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome.
    NCT03594773
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Cognitive Behavioral Therapy;   Behavioral: Interpersonal Psychotherapy
    Sponsors:   University of Pittsburgh;   Carnegie Mellon University
    Recruiting
  • Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)
    NCT03548675
    Condition:   Depressive Disorder, Major
    Intervention:   Drug: TCA treatment
    Sponsors:   Radboud University;   ZonMw: The Netherlands Organisation for Health Research and Development
    Recruiting
  • tDCS as add-on Treatment to Cognitive-Behavior Therapy in People With MDD
    NCT03548545
    Conditions:   Major Depressive Disorder;   CBT;   Transcranial Direct Current Stimulation
    Intervention:   Device: tDCS
    Sponsors:   University of Minho;   Fundação para a Ciência e a Tecnologia
    Recruiting
  • Switching From SSRI to Desvenlafaxine on Cognitive Functioning
    NCT03432221
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Desvenlafaxine
    Sponsors:   Corporacion Parc Tauli;   Pfizer
    Recruiting
  • Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
    NCT03367533
    Condition:   Depressive Disorder, Major
    Interventions:   Drug: Ketamine;   Drug: Perampanel;   Drug: Placebo
    Sponsor:   Yale University
    Recruiting
  • McLean and Genomind Prospective Study
    NCT03113890
    Conditions:   Major Depressive Disorder;   PTSD
    Interventions:   Genetic: Phlebotomy - Folate;   Genetic: Cheek Swab;   Other: Self-report surveys
    Sponsors:   Mclean Hospital;   Genomind, LLC
    Recruiting
  • Rapid Antidepressant Effects of Leucine
    NCT03079297
    Condition:   Major Depressive Disorder
    Interventions:   Drug: L-Leucine;   Other: Maltodextrin
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting
  • Neurobiology of Treatment Responses in MDD
    NCT03068247
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   University of Utah
    Not yet recruiting
  • Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
    NCT02977299
    Condition:   Treatment Resistant Major Depressive Disorder
    Interventions:   Drug: Aripiprazole;   Device: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Venlafaxine XR
    Sponsors:   Massachusetts General Hospital;   Patient-Centered Outcomes Research Institute
    Recruiting
  • Personalized rTMS for Resistant Depression
    NCT02863380
    Conditions:   Depressive Disorder;   Treatment-Resistant
    Interventions:   Procedure: Functional magnetic resonance imaging used to individualize rTMS protocol;   Device: Individualized rTMS (transcranial magnetic stimulation);   Device: Classical rTMS (transcranial magnetic stimulation);   Device: Classical tDCS (transcranial direct current stimulation)
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting
  • Loneliness and Occurrence of Suicide Attemps and Suicidal Ideas
    NCT02829671
    Condition:   Major Depressive Disorders
    Intervention:   Other: Clinical and biological assessment
    Sponsor:   University Hospital, Montpellier
    Not yet recruiting
  • Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients
    NCT02737540
    Condition:   Depressive Disorder, Major
    Intervention:  
    Sponsor:   Centre Hospitalier Universitaire de Nīmes
    Recruiting
  • Supportive and Supportive-Expressive Treatment for Depression
    NCT02728557
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Supportive-Expressive Therapy;   Behavioral: Supportive Therapy
    Sponsor:   University of Haifa
    Recruiting
  • Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex
    NCT02715128
    Condition:   Major Depressive Disorder
    Intervention:   Device: Transcranial direct current stimulation (tDCS)
    Sponsor:   Ludwig-Maximilians - University of Munich
    Not yet recruiting
  • Study of Neural Responses Induced by Antidepressant Effects
    NCT02674529
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Escitalopram;   Drug: Placebo
    Sponsor:   University of Pittsburgh
    Recruiting
  • Intra-nasal vs. Intra-venous Ketamine Administration
    NCT02644629
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Placebo;   Drug: Ketamine (1st phase);   Drug: Ketamine (2st phase)
    Sponsor:   Shalvata Mental Health Center
    Recruiting
  • MetAbolism vaRiability of VEnLafaxine
    NCT02590185
    Condition:   Major Depressive Disorders
    Intervention:   Drug: cocktail probe drugs
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting
  • miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
    NCT02418195
    Condition:   Major Depressive Disorder
    Intervention:   Drug: ketamine
    Sponsors:   University of Alabama at Birmingham;   National Institute of Mental Health (NIMH)
    Recruiting
  • Connectivity Affecting the Antidepressant REsponse Study
    NCT02332291
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Escitalopram;   Drug: Bupropion XL
    Sponsor:   Vanderbilt University Medical Center
    Recruiting
  • A Study of Aerobic Exercise for Patients With Bipolar Disorder
    NCT03353337
    Conditions:   Bipolar Disorder;   Cognitive Symptom
    Interventions:   Behavioral: aerobic exercise;   Behavioral: Placebo controlled group
    Sponsor:   Guangzhou Psychiatric Hospital
    Not yet recruiting
  • Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
    NCT03678194
    Conditions:   Depression;   Psychiatric Disorder;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases
    Intervention:   Device: Smartphone Support System
    Sponsor:   Centre Hospitalier Charles Perrens, Bordeaux
    Not yet recruiting
  • Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
    NCT03740009
    Conditions:   Perimenopausal Disorder;   Depression
    Intervention:   Drug: Bazedoxifene/Conjugated Estrogen
    Sponsors:   University of North Carolina, Chapel Hill;   Foundation of Hope, North Carolina
    Recruiting
  • SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project
    NCT03466346
    Conditions:   Depression, Unipolar;   Posttraumatic Stress Disorder;   Trauma
    Interventions:   Drug: Fluoxetine;   Behavioral: Interpersonal Psychotherapy
    Sponsors:   University of California, San Francisco;   University of Nairobi;   National Institute of Mental Health (NIMH);   Kenya Medical Research Institute;   University of California, San Diego;   Makerere University
    Not yet recruiting
  • Lipopolysaccharide (LPS) Challenge in Depression
    NCT03142919
    Condition:   Major Depressive Disorder
    Interventions:   Biological: Lipopolysaccharide;   Biological: Placebo
    Sponsor:   Laureate Institute for Brain Research, Inc.
    Recruiting
  • Characterization and Treatment of Adolescent Depression
    NCT03388606
    Condition:   Depression
    Intervention:  
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting
  • Step Away From Depression - Evaluation of a Pedometer Intervention With Inpatients With Major Depression
    NCT02850341
    Condition:   Depression
    Intervention:   Device: Pedometer
    Sponsor:   Charite University, Berlin, Germany
    Recruiting
  • The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System
    NCT03064477
    Conditions:   Emotional Disorder;   Anxiety Disorders;   Depressive Disorder
    Interventions:   Behavioral: Unified Protocol;   Behavioral: Cognitive Behavioral Therapy (TAU)
    Sponsors:   Universitat Jaume I;   Universidad de Zaragoza
    Recruiting
  • Reward Function and Therapy for Late-Life Depression
    NCT03688139
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Engage Therapy;   Behavioral: Supportive Therapy
    Sponsors:   Weill Medical College of Cornell University;   National Institute of Mental Health (NIMH)
    Recruiting
  • Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
    NCT03993457
    Condition:   Depression
    Interventions:   Drug: Escitalopram;   Drug: Bupropion
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting
  • Evaluation of mHealth for Serious Mental Illness
    NCT04068467
    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Major Depressive Disorder
    Interventions:   Other: Smartphone App;   Other: Waitlist Control
    Sponsor:   University of Washington
    Not yet recruiting
  • Research of Anatomo-functional Biomarkers in Schizophrenia
    NCT03996122
    Condition:   Schizophrenia
    Intervention:   Other: fMRI
    Sponsor:   University Hospital, Caen
    Recruiting
  • Effect of 4-session Metacognitive Training in Chinese Adult Outpatients With Schizophrenia Spectrum Disorders and Major Depressive Disorder
    NCT03449394
    Conditions:   Delusions;   Depression
    Intervention:   Other: Metacognitive Training
    Sponsor:   Chinese University of Hong Kong
    Recruiting
  • Affective Touching on Poststroke Depression
    NCT03789994
    Condition:   Post-stroke Depression
    Interventions:   Behavioral: Affective touch;   Other: Fine motor exercise
    Sponsors:   Chinese University of Hong Kong;   Research Grants Council
    Not yet recruiting
  • Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
    NCT02203552
    Conditions:   Anxiety Disorder;   Depression;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
    Interventions:   Drug: minocycline hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis;   Other: Questionnaire administration
    Sponsor:   Ohio State University Comprehensive Cancer Center
    Recruiting
  • Nitrous Oxide for the Treatment of Major Depressive Disorder
    NCT03869736
    Conditions:   Depression;   Major Depressive Disorder
    Interventions:   Drug: Nitrous Oxide;   Drug: Placebo
    Sponsor:   Bayside Health
    Recruiting
  • Study of the Synergistic Effects of Biofeedback and Transcranial Electrical Stimulation in Anxio-depressive Disorders
    NCT04189354
    Condition:   Anxio-depressive Disorder
    Intervention:   Device: Transcranial direct current stimulation (t-DCS) device
    Sponsor:   Tatiana Besse-Hammer
    Recruiting
  • Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder
    NCT04138290
    Condition:   Major Depressive Disorder
    Intervention:   Device: Predictix Antidepressant Software tool
    Sponsor:   Taliaz Ltd.
    Not yet recruiting
  • The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
    NCT04088448
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Placebo oral tablet;   Drug: Metformin
    Sponsor:   Sadat City University
    Recruiting
  • Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
    NCT04082806
    Condition:   Major Depressive Disorder
    Interventions:   Drug: GHB;   Drug: Trazodone;   Drug: Placebos
    Sponsor:   Erich Seifritz
    Not yet recruiting
  • A Study of JNJ-61393215 in the Treatment of Depression
    NCT04080752
    Condition:   Major Depressive Disorder With Anxious Distress
    Interventions:   Drug: JNJ-61393215;   Drug: Placebo
    Sponsor:   Janssen Research & Development, LLC
    Recruiting
  • The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Antidepressants in Major Depressive Disorder Patients
    NCT04069819
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Cilostazol 100 MG Oral Tablet;   Drug: Escitalopram;   Drug: Placebo
    Sponsor:   Sadat City University
    Recruiting
  • Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool
    NCT04031157
    Condition:   Major Depressive Disorder
    Intervention:   Device: Predictix Antidepressant
    Sponsor:   Taliaz Ltd.
    Recruiting
  • Efficacy of Eye Movement Desensitization & Reprocessing Versus Cognitive Behavioral Therapy in Post-Traumatic Stress and Depressive Disorders
    NCT04021329
    Condition:   Efficacy of Psychotherapy
    Intervention:   Behavioral: CBT Therapy
    Sponsor:   Khushal Khan Khattak Univeristy, Karak, Pakistan
    Not yet recruiting
  • A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Subjects With Major Depressive Disorder
    NCT04007367
    Condition:   Major Depressive Disorder
    Interventions:   Drug: SAGE-217;   Drug: Placebo
    Sponsor:   Sage Therapeutics
    Recruiting
  • Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
    NCT04000009
    Condition:   Adjunctive Treatment of Major Depressive Disorder
    Intervention:   Drug: Pimavanserin
    Sponsor:   ACADIA Pharmaceuticals Inc.
    Recruiting
  • Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
    NCT03999918
    Condition:   Adjunctive Treatment of Major Depressive Disorder
    Interventions:   Drug: Pimavanserin;   Drug: Placebo
    Sponsor:   ACADIA Pharmaceuticals Inc.
    Recruiting
  • Mechanism of Action of tACS for the Treatment of MDD
    NCT03994081
    Conditions:   Major Depressive Disorder;   MDD
    Interventions:   Device: tACS;   Device: Sham tACS
    Sponsors:   University of North Carolina, Chapel Hill;   Foundation of Hope for Research and Treatment of Mental Illness
    Not yet recruiting
  • Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
    NCT03968159
    Condition:   Adjunctive Treatment of Major Depressive Disorder
    Interventions:   Drug: Pimavanserin;   Drug: Placebo
    Sponsor:   ACADIA Pharmaceuticals Inc.
    Recruiting
  • Adjunctive D-Cycloserine in Major Depressive Disorder
    NCT03937596
    Condition:   Major Depressive Disorder
    Interventions:   Drug: D-cycloserine;   Device: Transcranial Magnetic Stimulator;   Drug: Placebo oral capsule
    Sponsor:   University of Calgary
    Not yet recruiting
  • Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
    NCT03872492
    Condition:   Depressive Disorder, Major
    Intervention:   Other: Digital Assessment on mobile
    Sponsor:   Ad scientiam
    Recruiting
  • A Study of Psilocybin for Major Depressive Disorder (MDD)
    NCT03866174
    Condition:   Depressive Disorder, Major
    Interventions:   Drug: Psilocybin;   Drug: Niacin
    Sponsors:   Usona Institute;   Signant Health;   The Emmes Company, LLC
    Recruiting
  • Study With Vortioxetine on Emotional Functioning in Patients With Depression
    NCT03835715
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Vortioxetine
    Sponsor:   H. Lundbeck A/S
    Recruiting
  • Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD)
    NCT03769350
    Condition:   Major Depressive Disorder
    Intervention:   Device: Smartphone-delivered CBT for MDD
    Sponsors:   Massachusetts General Hospital;   Telefónica S.A.
    Not yet recruiting
  • Coaching Intervention in Women At-risk of Depressive Disorders
    NCT03751696
    Condition:   Depressive Disorder
    Interventions:   Behavioral: Group Coaching;   Behavioral: 'General wellbeing' class (GMWP)
    Sponsor:   The University of Hong Kong
    Not yet recruiting
  • to Explore the Effective Doses, and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets
    NCT03739632
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Hypidone Hydrochloride tablets;   Other: Placebo
    Sponsor:   Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
    Not yet recruiting
  • The Object of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
    NCT03739203
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Cariprazine;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
    NCT03738215
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Cariprazine;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
    NCT03737474
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Brexpiprazole
    Sponsor:   Otsuka Pharmaceutical Co., Ltd.
    Recruiting
  • Group Metacognitive Therapy vs Clinical Management for Depression
    NCT03711123
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Group metacognitive therapy;   Behavioral: Clinical management
    Sponsor:   University of Oslo
    Recruiting
  • Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment
    NCT03703414
    Condition:   Major Depressive Disorder
    Intervention:   Diagnostic Test: Fecal microbiota composition analysis and blood cytokine level analysis
    Sponsor:   Ziv Hospital
    Not yet recruiting
  • A Study of Brexpiprazole in Patients With Major Depressive Disorder
    NCT03697603
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Brexpiprazole;   Drug: Placebo
    Sponsor:   Otsuka Pharmaceutical Co., Ltd.
    Recruiting
  • A Multi-component Intervention to Improve Medication Adherence in People With Depressive Disorders
    NCT03668457
    Condition:   Depressive Disorder
    Interventions:   Behavioral: Intervention to Patients;   Behavioral: Intervention to Psychiatrists;   Other: Control
    Sponsors:   Servicio Canario de Salud;   University of La Laguna
    Not yet recruiting
  • The Antidepressant Advisor Study
    NCT03628027
    Condition:   Major Depressive Disorder
    Intervention:   Device: Computerised decision support algorithm
    Sponsors:   King's College London;   NHS Lambeth Clinical Commissioning Group;   EMIS PLC;   D'Or Institute for Research and Education
    Recruiting
  • Biomarkers of Theta Burst Stimulation in Major Depressive Disorder
    NCT03626181
    Condition:   Depressive Disorder, Treatment-Resistant
    Intervention:   Device: Theta Burst Stimulation ( Transcranial Magnetic Stimulation)
    Sponsor:   University of Calgary
    Recruiting
  • Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents
    NCT03626103
    Conditions:   Depressive Disorder;   Violence
    Interventions:   Behavioral: + Brief ED Intervention (BI);   Behavioral: + Text
    Sponsors:   Rhode Island Hospital;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting
  • Olfactory Training and Emotional State
    NCT03605524
    Conditions:   Depressive Symptoms;   Depressive Disorder, Major
    Intervention:   Other: Sensory training
    Sponsor:   University Hospital, Tours
    Recruiting
  • Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
    NCT03569475
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Levomilnacipran ER;   Drug: Fluoxetine;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
    NCT03559192
    Condition:   Depressive Disorder, Major
    Interventions:   Drug: JNJ-67953964;   Drug: Placebo
    Sponsor:   Janssen Research & Development, LLC
    Recruiting
  • The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder
    NCT03558256
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Mindfulness-based Cognitive Therapy;   Drug: Medication
    Sponsor:   Shanghai Mental Health Center
    Recruiting
  • Real-life Effectiveness of Vortioxetine in Depression
    NCT03555136
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Vortioxetine
    Sponsor:   H. Lundbeck A/S
    Recruiting
  • Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
    NCT03554174
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Low Dose Psilocybin;   Drug: Placebo;   Drug: Medium Dose Psilocybin
    Sponsors:   Yale University;   Heffter Research Institute
    Recruiting
  • A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
    NCT03538691
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Brexpiprazole;   Drug: Placebo;   Drug: Citalopram Hydrobromide;   Drug: Escitalopram;   Drug: Fluoxetine;   Drug: Paroxetine;   Drug: Sertraline;   Drug: Duloxetine;   Drug: Venlafaxine Extended Release Oral Capsule
    Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
    Recruiting
  • Cycloserine rTMS Plasticity Augmentation in Depression
    NCT03511599
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Cycloserine;   Device: Transcranial Magnetic Stimulation;   Drug: Placebo Oral Tablet
    Sponsor:   University of Calgary
    Recruiting
  • A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
    NCT03446846
    Condition:   Major Depressive Disorder
    Interventions:   Drug: MIN-117 2.5 mg;   Drug: MIN-117 5.0 mg;   Drug: Placebo
    Sponsor:   Minerva Neurosciences
    Recruiting
  • Does Nurse Semi Structured Interview Added to a rTMS Improve Patients With Major Depressive Disorder?
    NCT03436823
    Condition:   Depressive Disorder, Major
    Interventions:   Other: nurse semi-structured interview;   Other: Music & Relaxation with eyes closed
    Sponsors:   Rennes University Hospital;   Ministry of Health, France
    Recruiting
  • NMDA Modulation in Major Depressive Disorder in Late- Life
    NCT03414931
    Condition:   Depressive Disorder, Major
    Interventions:   Drug: NMDA;   Drug: Sertraline;   Drug: Placebo - Cap
    Sponsor:   Chang Gung Memorial Hospital
    Recruiting
  • To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD
    NCT03404466
    Condition:   Major Depressive Disorder
    Intervention:   Drug: Hypidone Hydrochloride tablets
    Sponsor:   Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
    Recruiting
  • Movement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDD
    NCT03403881
    Condition:   Major Depressive Disorder
    Interventions:   Behavioral: Physical activity promotion + TAU;   Behavioral: Control
    Sponsor:   Hospital de Clinicas de Porto Alegre
    Recruiting
  • A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
    NCT03395353
    Condition:   Depressive Disorder
    Intervention:   Drug: Duloxetine Hydrochloride
    Sponsors:   Eli Lilly and Company;   Shionogi
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC